BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,360.00
-70.00 (-1.29%)
At close: Jan 9, 2026
BioNote Market Cap
BioNote has a market cap or net worth of 543.3 billion as of January 9, 2026. Its market cap has increased by 14.48% in one year.
Market Cap
543.30B
Enterprise Value
196.82B
Revenue
115.09B
Ranking
n/a
PE Ratio
4.62
Stock Price
5,360.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 543.30B, a decrease of -49.93%. That is a compound annual growth rate of -20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 543.30B | -2.01% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.93T |
| Celltrion | 47.48T |
| ALTEOGEN | 27.33T |
| ABL Bio | 11.27T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.46T |
| HLB Co., Ltd. | 6.66T |
| LigaChem Biosciences | 6.62T |